Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MKTVIF75HV for relapsing-remitting multiple sclerosis
ACTRN12606000359538Phase 3Not yet recruiting
- Sponsor
- Melbourne Health
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Calcirol in multiple sclerosis (MS) (2 arms), sponsored by Melbourne Health. Primary endpoint: Total number of new gadolinium-enhancing lesions on MRI during 6 months. Planned start Aug 2006; status: not yet recruiting.
02
Drugs
Calcirol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on ACTRN12606000359538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000359538.